— Know what they know.
Not Investment Advice

SYNL NASDAQ

Synalloy Corporation
1W: +19.7% 1M: +18.4% 3M: +7.2% 1Y: +45.5% 3Y: -2.1% 5Y: +46.2%
$15.57
Last traded 2022-08-10 — delisted
NASDAQ · Basic Materials · Steel · $158.8M mcap · 7M float · 0.353% daily turnover

Balance Sheet Trends

Total Assets
$112M -24.0% ▼
5Y CAGR: -11.6%
Total Liabilities
$25M -53.6% ▼
5Y CAGR: -27.7%
Shareholders Equity
$87M -7.0% ▼
5Y CAGR: +1.6%
Cash & Investments
$58M +257.6% ▲
5Y CAGR: +200.3%
Total Debt
$13M -59.4% ▼
5Y CAGR: -26.5%
Net Debt
-$44M -363.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$2M$16M$24M$16M$58M
Short-Term Investments$0$62M$24M$0$0
Cash & ST Investments$2M$78M$48M$16M$58M
Net Receivables$50M$0$0$24M$10M
Inventory$103M$0$0$41M$9M
Other Current Assets$5M$495K$934K$1M$7M
Total Current Assets$160M$80M$50M$83M$83M
Property, Plant & Equip.$75M$22M$18M$54M$25M
Goodwill & Intangibles$27M$0$0$7M$3M
Long-Term Investments-$3M$0$0$0$0
Other Non-Current Assets$4M$9M$8M$3M$954K
Total Non-Current Assets$106M$31M$26M$64M$29M
Total Assets$266M$111M$76M$147M$112M
— Liabilities —
Accounts Payable$32M$2M$1M$13M$5M
Short-Term Debt$4M$0$0$2M$1M
Deferred Revenue$441K$0$0$1M$0
Other Current Liabilities$14M$882K$21M$6M$11M
Total Current Liabilities$50M$12M$30M$22M$12M
Long-Term Debt$101M$0$0$31M$12M
Other Non-Current Liab.$89K$0$0$51K$45K
Total Non-Current Liabilities$104M$16M$12M$31M$13M
Total Liabilities$154M$28M$43M$54M$25M
— Equity —
Common Stock$11M$5K$10K$11M$11M
Retained Earnings$63M-$357M-$418M$45M$46M
Accumulated OCI$0-$161K$6K$0$0
Total Stockholders Equity$112M$83M$33M$94M$87M
Total Liabilities & Equity$266M$111M$76M$147M$112M
— Key Metrics —
Total Debt$105M$20M$17M$33M$13M
Net Debt$103M$4M-$7M$17M-$44M
Total Investments-$3M$62M$24M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms